Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.19
-0.07 (-0.68%)
At close: May 7, 2026, 4:00 PM EDT
10.36
+0.17 (1.67%)
After-hours: May 7, 2026, 7:12 PM EDT

Arvinas Revenue

In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%. Arvinas had revenue of $9.50M in the quarter ending December 31, 2025, a decrease of -83.95%.

Revenue (ttm)
$262.60M
Revenue Growth
-0.30%
P/S Ratio
2.48
Revenue / Employee
$1,067,480
Employees
246
Market Cap
651.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 201814.32M6.75M89.00%
Dec 31, 20177.58M909.86K13.64%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CorMedix311.71M
Zevra Therapeutics122.29M
Gyre Therapeutics117.05M
Sutro Biopharma102.48M
Aclaris Therapeutics8.37M
Revenue Rankings